Orthofix Medical Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Orthofix Medical Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $400.00K, a 100.00% increase from fiscal 2024.
- Orthofix Medical Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $200.00K.
- Orthofix Medical Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $0.00.
- Orthofix Medical Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-02-24 | |
| 2024-12-31 | $200.00K 10-K · filed 2025-02-25 | |
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 | |
| 2022-12-31 | $0.00 10-K · filed 2023-03-06 | |
| 2021-12-31 | $3.30M 10-K · filed 2022-02-25 | |
| 2020-12-31 | $2.70M 10-K · filed 2021-02-26 | |
| 2019-12-31 | $2.80M 10-K · filed 2020-02-24 | |
| 2018-12-31 | $2.80M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |